Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.

Y, Shiratori; Y, Ito; O, Yokosuka; F, Imazeki; R, Nakata; N, Tanaka; Y, Arakawa; E, Hashimoto; K, Hirota; H, Yoshida; Y, Ohashi; M, Omata

doi:10.7326/0003-4819-142-2-200501180-00009

Public

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.

Shared by NobleBlocks on Jan 1, 2005 • 12:00 AM UTC

Authors:

Shiratori Y

Ito Y

Yokosuka O

Abstract

<h4>Background</h4>Although cirrhosis is a major risk factor for development of hepatocellular carcinoma, no definitive prospective analyses have assessed the long-term efficacy of antiviral therapy in cirrhotic patients.<h4>Objective</h4>To elucidate the role of antiviral therapy in the suppression...

Discussions